- Home
- ROIV vs PCTY Comparison
ROIV vs PCTY Comparison
Compare ROIV & PCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- PCTY
- Stock Information
- Founded
- ROIV 2014
- PCTY 1997
- Country
- ROIV United Kingdom
- PCTY United States
- Employees
- ROIV N/A
- PCTY N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- PCTY Computer Software: Prepackaged Software
- Sector
- ROIV Health Care
- PCTY Technology
- Exchange
- ROIV Nasdaq
- PCTY Nasdaq
- Market Cap
- ROIV 8.6B
- PCTY 9.9B
- IPO Year
- ROIV N/A
- PCTY 2014
- Fundamental
- Price
- ROIV $16.66
- PCTY $149.47
- Analyst Decision
- ROIV Strong Buy
- PCTY Buy
- Analyst Count
- ROIV 8
- PCTY 17
- Target Price
- ROIV $19.94
- PCTY $223.25
- AVG Volume (30 Days)
- ROIV 8.3M
- PCTY 622.5K
- Earning Date
- ROIV 11-11-2025
- PCTY 11-04-2025
- Dividend Yield
- ROIV N/A
- PCTY N/A
- EPS Growth
- ROIV N/A
- PCTY 10.74
- EPS
- ROIV N/A
- PCTY 4.02
- Revenue
- ROIV $23,233,000.00
- PCTY $1,595,221,000.00
- Revenue This Year
- ROIV N/A
- PCTY $9.77
- Revenue Next Year
- ROIV $200.91
- PCTY $8.97
- P/E Ratio
- ROIV N/A
- PCTY $37.63
- Revenue Growth
- ROIV N/A
- PCTY 13.74
- 52 Week Low
- ROIV $8.73
- PCTY $149.85
- 52 Week High
- ROIV $16.79
- PCTY $223.80
- Technical
- Relative Strength Index (RSI)
- ROIV 78.13
- PCTY 27.88
- Support Level
- ROIV $15.91
- PCTY $151.96
- Resistance Level
- ROIV $16.39
- PCTY $157.45
- Average True Range (ATR)
- ROIV 0.48
- PCTY 3.51
- MACD
- ROIV -0.02
- PCTY -0.26
- Stochastic Oscillator
- ROIV 92.05
- PCTY 4.03
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PCTY Paylocity Holding Corporation
Founded in 1997, Paylocity is a cloud-based human capital management and payroll platform servicing midmarket customers. The company's average client size is around 150 employees. Its products help with recruiting and onboarding, payroll, time and labor, human resources, benefits, learning, and performance and compensation workflows. In fiscal 2025, the company generated over $1.5 billion in revenue across more than 41,000 customers.